Expand NXTC Menu
NXTC MENU

NXTC Latest Press Releases

-- July 24, 2026 --

Halper Sadeh LLC is Investigating Whether VEEE, NXTC, TCBK, FHB are Obtaining Fair Deals for their Shareholders PRNewswire 4:38 PM

-- July 23, 2026 --

Halper Sadeh LLC is Investigating Whether VEEE, NXTC, TCBK, FHB are Obtaining Fair Deals for their Shareholders Globe Newswire 9:23 AM

-- July 22, 2026 --

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--VEEE, NXTC, TCBK, and FHB PRNewswire 2:04 PM

-- July 21, 2026 --

Are CRNX, VEEE, NXTC, TCBK Obtaining Fair Deals for their Shareholders? PRNewswire 2:51 PM
Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders Globe Newswire 7:39 AM

-- July 14, 2026 --

NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders Globe Newswire 6:42 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of NextCure, Inc. (NASDAQ: NXTC) PRNewswire 1:34 PM
Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders PRNewswire 11:41 AM
NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders Business Wire 10:59 AM
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy Globe Newswire 6:00 AM

-- June 4, 2026 --

NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers Globe Newswire 8:00 AM

-- June 1, 2026 --

NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026 Globe Newswire 8:00 AM

-- May 7, 2026 --

NextCure Provides Business Update and Reports First Quarter 2026 Financial Results Globe Newswire 4:05 PM

-- May 4, 2026 --

NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers Globe Newswire 7:05 AM

-- April 21, 2026 --

NextCure and Simcere's SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026 Globe Newswire 10:15 AM

-- April 7, 2026 --

NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer Globe Newswire 8:05 AM

-- March 31, 2026 --

NextCure and Simcere's SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026 Globe Newswire 4:05 PM

-- March 5, 2026 --

NextCure Provides Business Update and Reports Full Year 2025 Financial Results Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes